Food Allergy News and Research

Australia Tennis Match Interrupted by Anaphylaxis

Tennis fans interrupted the Australian Open to save a woman from a severe allergic reaction. Someone in the crowd tossed epinephrine – the first treatment used for anaphylaxis, or a severe allergic reaction – from an upper deck to rush it to her aid. In the U.S., laws to allow access to stock epinephrine in public places, like sports stadiums, are beginning to take shape. New Jersey passed such a law earlier this month. Is your state considering a similar law? Check and take...

Do You Know When and How to Use Epinephrine for Allergy Emergencies?

A recent study asked 859 families about the food allergy care they received from their allergist and pediatrician. Some of the questions were about the way they were treated. Other questions were about the information they were given. The results showed both good news and bad news. Most parents felt very good about their doctors Nearly all said that they were treated with courtesy and respect. They also said that the doctor listened to their questions and concerns. “I was happy to see...

Infant Fed Only Almond Milk Develops Scurvy from Lack of Nutrients

A recent report shows the dangers of feeding infants alternative milks instead of breast milk or formula. Doctors diagnosed an 11-month-old infant with scurvy, according to a report in Medical Daily . The baby boy was breastfed for two months. He developed a skin condition due to suspected milk allergy and his diet was changed to just almond milk. The almond milk caused a lack of nutrition, including vitamin C. The baby had bone fractures and was immobile. Doctors diagnosed him with scurvy.

Mylan Confirms Availability of EpiPen Auto-Injector for U.S. Patients Affected by Sanofi's Auvi-Q Recall

Mylan Confirms Availability of EpiPen® (epinephrine injection) Auto-Injector for U.S. Patients Affected by Sanofi's Auvi-Q® (epinephrine injection, USP) Recall [Press Release]   HERTFORDSHIRE, England and PITTSBURGH, Oct. 29, 2015 /PRNewswire/ -- Mylan Specialty, a division of Mylan N.V. (Nasdaq: MYL ) which markets and distributes EpiPen ® (epinephrine injection) Auto-Injector, today commented on the voluntary nationwide recall of Sanofi's Auvi-Q ® (epinephrine...

Important Recall Notice: All Auvi-Q Epinephrine Auto-Injectors

Sanofi US Issues Voluntary Nationwide Recall of Auvi-Q ® Due to Potential Inaccurate Dosage Delivery   [Press Release]   Company Contact Karen Sutherland Tel. : +1 908-989-0726 Email : USMediaRelations@Sanofi.com     Bridgewater, N.J. - October 30, 2015 - Sanofi US is voluntarily recalling all Auvi-Q® (epinephrine injection, USP).The recall involves all Auvi-Q currently on the market and includes both the 0.15 mg and 0.3 mg strengths for hospitals,...

×
×
×
×